Ginkgo Bioworks falls short on Q4 revenue and projects weak 2025 guidance. Learn about DNA stock's valuation risks, cash ...

Ginkgo Bioworks' restructuring has resulted in a dramatic reduction in cash burn in recent quarters. Read why I think DNA ...

As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

There’s plenty of empty lab space around Greater Boston these days, and a lot of competition for life-science tenants. Now ...

Ginkgo already canceled its plans to move into Biofab1, a new 260,000-square-foot lab data center it's been building near its ...

A local subsidiary of global conglomerate Danaher has notifed the state that it plans to lay off 85 employees in Massachusetts.

Getting herbal Viagra is easy — you can usually find these cleverly packaged and over-hyped supplements at the convenience ...

Discover the incredible resilience of the ginkgo tree, a living fossil that survived nuclear devastation and thrives ...

Full Year 2024 Results Key Financial Results Revenue: US$227.0m (down 9.7% ...

Joseph Fridman; Director of Communications and Corporate Affairs; Ginkgo Bioworks Holdings Inc. Jason Kelly; Chief Executive Officer, Founder, Director; Ginkgo Biowo ...

Ginkgo biloba benefits have been claimed for centuries, with health treatments meant to help improve cognitive function and treat asthma, COPD, and bladder disorders. Studies suggest that it acts on ...